Cours MediXall Group, Inc. Other OTC
Actions
MDXL
US58504K1043
Equipement et technologie médicale avancés
CA 2021 | 15 k 13,69 k | CA 2022 | 59,27 k 54,12 k | Capitalisation | 77,59 M 70,85 M |
---|---|---|---|---|---|
Résultat net 2021 | -6 M -5,48 M | Résultat net 2022 | -6 M -5,48 M | VE / CA 2021 | 7 599 x |
Dette nette 2021 | 252 k 230 k | Dette nette 2022 | 2,82 M 2,57 M | VE / CA 2022 | 1 357 x |
PER 2021 |
-17
x | PER 2022 |
-10,5
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 85,16% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Travis Jackson
CEO | Chief Executive Officer | - | 14/06/22 |
Shane Glavin
DFI | Director of Finance/CFO | - | 06/12 |
Frank Dickerson
IRC | Investor Relations Contact | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Marino
CEO | Chief Executive Officer | 52 | 01/06/13 |
Travis Jackson
CEO | Chief Executive Officer | - | 14/06/22 |
Robert Hood
BRD | Director/Board Member | - | 10/10/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+8,07% | 219 Md | |
+6,59% | 183 Md | |
+11,26% | 133 Md | |
+26,57% | 108 Md | |
+0,65% | 63,06 Md | |
+13,35% | 52,02 Md | |
-0,62% | 48,2 Md | |
-0,93% | 40,37 Md | |
+11,54% | 39,35 Md |